Avid Radiopharmaceuticals
LisaAnn Trembath has a diverse work experience in the field of medical imaging and clinical research. LisaAnn began their career as a Research Technologist and Computer Application Specialist at the Medical College of Wisconsin, where they conducted pre-clinical and clinical research studies. LisaAnn then served as a Research Coordinator, overseeing the planning and implementation of clinical drug and device studies.
Trembath also worked as a Clinical Research Associate, providing consultant services and monitoring oncology diagnostic and therapeutic radiopharmaceutical trials. LisaAnn later joined Affiliated Research Centers as a Project Manager, managing multiple research projects in urology.
In 1998, Trembath joined Bristol-Myers Squibb Medical Imaging as a Clinical Specialist, where they specialized in cardiac imaging radiopharmaceuticals and provided training to medical professionals. LisaAnn then became a Senior Clinical Specialist, serving as a clinical liaison between the company and local accounts.
Trembath continued their career at Cellectar, Inc., where they were the Manager of Medical Affairs and Clinical Trials. In this role, they were a key member of the clinical operations team, involved in the design and implementation of phase I dosimetry trials.
LisaAnn also worked at Trembath Consulting LLC as a Clinical Research Consultant, providing services for clinical trials that utilized medical imaging such as PET scanning.
Trembath's experience in clinical imaging operations and global PET technology led their to join Avid Radiopharmaceuticals as the Associate Director of Clinical Imaging Operations. In this role, they supervised and coordinated the activities of a specialized team and established training programs. LisaAnn later became the Director of US and Global Clinical Imaging Scientists and eventually the Chief Operating Officer for Global Imaging.
Additionally, Trembath served as the CTN Education Committee Chair at the Society of Nuclear Medicine and Molecular Imaging.
Overall, LisaAnn Trembath has demonstrated expertise in medical imaging, clinical research, and project management throughout their career.
LisaAnn Trembath's education history includes a Master of Science in Business Management (MSM) from Cardinal Stritch University, which they obtained from 2004 to 2006. Prior to that, they completed a certificate program in Nuclear Medicine Technology (CNMT) at The Ohio State University from 1984 to 1985. LisaAnn also earned a Master of Science in Business Management (MSM) from Cardinal Stritch University in 1985, concurrently with their certification as a Nuclear Medicine Technologist. LisaAnn's undergraduate degree is a Bachelor of Arts in Natural Science (BA) from Concordia University-St. Paul, which they obtained from 1980 to 1984.
Avid Radiopharmaceuticals
1 followers
At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avid's pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages of pathological change; allowing early treatment and management of people at risk - perhaps before before symptoms of disease can develop.